Skip to main content

Advertisement

SpringerLink
Log in

Systemic Lupus Erythematosus Involving the Nervous System: Presentation, Pathogenesis, and Management

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Neuropsychiatric syndromes in systemic lupus erythematosus (SLE) have a wide range of severity and phenotype and are fairly common. Presentations are seen involving both central and peripheral nervous systems. Pathogenic mechanisms are thought to include vascular occlusion and hemorrhage, antineuronal antibodies, cytokine effects, choroid plexus dysfunction, neuroendocrine–immune effects, and direct central nervous system (CNS) tissue injury. Work-up includes serum, cerebrospinal fluid (CSF), and imaging studies. Treatment is based on severity and phenotype and includes steroids, anticoagulants, antidepressants, and cytotoxic approaches. Much remains to be done in terms of further elucidation of pathologic processes, correlation of these mechanisms with specific phenotypes, and management of the most severe presentations of neuropsychiatric lupus erythematosus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Stojanovich L et al (2007) Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 6:421–426

    Article  PubMed  CAS  Google Scholar 

  2. West S (2006) Systemic lupus erythematosus and the nervous system. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematosus, 6th edn. Lippincott, Williams and Wilkins, Philadelphia, p 707–736

    Google Scholar 

  3. Ahrens D et al (1996) Expression of matrix metalloproteinase 9 (96kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39(9):1576–1587

    Article  PubMed  CAS  Google Scholar 

  4. Matsukawa Y et al (1994) Suicide in patients with systemic lupus erythematosus: a clinical analysis of seven suicidal patients. Lupus 3(1):31–35

    Article  PubMed  CAS  Google Scholar 

  5. Karassa F et al (2003) Suicide attempts in patients with systemic lupus erythematosus. Ann Rheum Dis 62(1):58–60

    Article  PubMed  CAS  Google Scholar 

  6. Sullivan-Marx E et al (2001) Delirium. In: Maddox G (ed) The encyclopedia of aging, 3rd edn. Springer, New York, NY

    Google Scholar 

  7. Jennekens F et al (2002) The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology 41(6):605–618

    Article  PubMed  CAS  Google Scholar 

  8. Pompei P et al (1994) Delirium in hospitalized older persons: outcomes and predictors. J Am Geriatr Soc 42(8):809–815

    PubMed  CAS  Google Scholar 

  9. Kotzin BL, Kozora E (2001) Anti-DNA meets NMDA in neuropsychiatric lupus. Nat Med 7(11):1175–1176

    Article  PubMed  CAS  Google Scholar 

  10. Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci 103(52):19854–19859

    Article  PubMed  CAS  Google Scholar 

  11. Wekking E et al (1991) Cognitive and emotional disturbances in systemic lupus erythematosus. Psychother Psychosom 55(2–4):126–131

    Article  PubMed  CAS  Google Scholar 

  12. Ginsburg K et al (1992) A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 35(7):776–782

    Article  PubMed  CAS  Google Scholar 

  13. Kiss E, Shoenfeld Y (2007) Are anti-ribosomal p protein antibodies relevant in systemic lupus erythematosus? Clin Rev Allergy Immunol 32(1):37–46

    PubMed  CAS  Google Scholar 

  14. Shoenfeld Y et al (2007) To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J Autoimmun 28(2–3):165–169

    Article  PubMed  CAS  Google Scholar 

  15. Toubi E, Shoenfeld Y (2007) Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 6(3):119–125

    Article  PubMed  CAS  Google Scholar 

  16. Sun KH et al (2005) Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-α and iNOS in activated RAW macrophage cell line. J Autoimmun 24:135–143

    Article  PubMed  CAS  Google Scholar 

  17. Strous RD, Shoenfeld Y (2006) To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev 6:54–60

    Article  PubMed  CAS  Google Scholar 

  18. Muscal E, Myones B (2007) The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus. Autoimmun Rev 6(4):215–217

    Article  PubMed  Google Scholar 

  19. Cavazzana I et al (2007) Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? J Autoimmun 28(2–3):160–164

    Article  PubMed  CAS  Google Scholar 

  20. Kozora E et al (2001) Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. J Int Neuropsychol Soc 7(6):745–754

    Article  PubMed  CAS  Google Scholar 

  21. Hanly J et al (1997) Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 40(8):1542–1543

    Article  PubMed  CAS  Google Scholar 

  22. Loukkola J et al (2003) Cognitive impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: a population-based neuropsychological study. J Clin Exp Neuropsychol 25(1):145–151

    Article  PubMed  Google Scholar 

  23. Rao S (2004) Cognitive function in patients with multiple sclerosis: impairment and treatment. Int J M S Care 6(1):9–22

    Google Scholar 

  24. Ishikura R et al (2001) Factors associated with anxiety, depression and suicide ideation in female outpatients with SLE in Japan. Clin Rheumatol 20(6):394–400

    Article  PubMed  CAS  Google Scholar 

  25. Denburg J et al (1987) Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37(3):464–467

    PubMed  CAS  Google Scholar 

  26. Fragoso-Loyo H et al (2007) Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 56(4):1242–1250

    Article  PubMed  CAS  Google Scholar 

  27. Stoppe G et al (1990) Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 40(2):304–308

    PubMed  CAS  Google Scholar 

  28. Weiner S et al (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 59(5):377–385

    Article  PubMed  CAS  Google Scholar 

  29. Watreloo K et al (2002) Neurospychological function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology 41(4):411–415

    Article  Google Scholar 

  30. Carlomagno S et al (2000) Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 247(4):273–279

    Article  PubMed  CAS  Google Scholar 

  31. Carbotte R et al (1995) Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatology 22:863–867

    CAS  Google Scholar 

  32. Denburg S et al (1997) Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report. J Rheumatology 24:998–1003

    CAS  Google Scholar 

  33. Gonzales-Crespo M et al (1995) Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatology 34(11):1055–1060

    Article  Google Scholar 

  34. Monastero R et al (2001) Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. Neurol Sci 184:33–39

    Article  CAS  Google Scholar 

  35. Denburg S et al (1987) Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 9(4):323–339

    Article  PubMed  CAS  Google Scholar 

  36. Hahn BH, Grossman J, Chen W, McMahon M (2007) The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28(2–3):69–75

    Article  PubMed  CAS  Google Scholar 

  37. Blank M, Shoenfeld Y (2007) B cell targeted therapy in autoimmunity. J Autoimmun 28(2–3):62–68

    Article  PubMed  CAS  Google Scholar 

  38. Holvast B, Huckriede A, Kallenberg CG, Bijl M (2007) Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 6(5):300–305

    Article  PubMed  CAS  Google Scholar 

  39. Elkayam O, Ablin J, Caspi D (2007) Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev 6(5):312–314

    Article  PubMed  Google Scholar 

  40. Koike T, Bohgaki M, Amengual O, Atsumi T (2007) Antiphospholipid antibodies: lessons from the bench. J Autoimmun 28(2–3):129–133

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical and Research Fellow, Department of Medicine, Division of Rheumatology, University of Colorado, 1775 N. Ursula Street, Rm 3102, Mail Stop B115, PO Box 6511, Aurora, CO, 80045, USA

    Julia J. Rhiannon

Authors
  1. Julia J. Rhiannon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julia J. Rhiannon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rhiannon, J.J. Systemic Lupus Erythematosus Involving the Nervous System: Presentation, Pathogenesis, and Management. Clinic Rev Allerg Immunol 34, 356–360 (2008). https://doi.org/10.1007/s12016-007-8052-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-007-8052-z

Keywords

Search

Navigation